Fabio Palombo

6PUBLICATIONS
21CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMicrofluidics and nanofluidicsAgricultural molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 13, 2026
Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenic.

|Mar 30, 2023
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms.

Federico D'Alessio, Lucia Lione, Erika Salvatori

|Jul 27, 2022
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model.

Mirco Compagnone, Eleonora Pinto, Erika Salvatori

|Feb 03, 2022
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy.

Erika Salvatori, Lucia Lione, Mirco Compagnone

|Apr 02, 2021
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition.

Lucia Lione, Erika Salvatori, Adriana Petrazzuolo

|Feb 16, 2019
Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.

Luigi Aurisicchio, Erika Salvatori, Lucia Lione

Pageof 1

Frequent Collaborators

3 joint publications

Erika Salvatori

3 joint publications

Lucia Lione

3 joint publications

Eleonora Pinto

3 joint publications

Antonella Conforti